NCT Number: NCT05458544
Phase: Phase 1|Phase 2
Trial Summary: Phase 1: The objective of the Phase 1 part of the clinical trial is to verify safety and tolerability (dose-limiting toxicity [DLT], maximum tolerated dose [MTD]) of a single 3 – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): FutureChem
Acronym: LUCIDA
[Lu-177]Ludotadipep in Castration-resistant Prostate Cancer(CRPC): Investigation of Drug and Application
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives